Cartesian Therapeutics, Inc. — Director's Dealing 2017

Nov 20, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2017-11-17

Reporting Person: Smolinski Stephen (Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-17	Stock Option (right to buy)	$10.23	A	80000	Acquired	2027-11-16	Common Stock (80000)	Direct

Footnotes

F1: This option vests as to 25% of the shares on October 26, 2018. The remainder of the shares will vest in 36 equal monthly installments thereafter.